Rabies is a viral disease that affects the central nervous system of mammals, ultimately affecting the brain cells and causing death [1]. The virus is commonly transmitted to humans through bites by rabid animals, especially dogs [2]. Rabies is a significant public health threat and the most underreported neglected tropical disease in low-income countries [3, 4]. Rabies is estimated to cause 59,000 human deaths annually in over 150 countries, with 95% of cases occurring in Africa and Asia [5].
Rabies has a significant impact on communities. The disease is associated with an increased economic burden, with control and management costs estimated to reach up to $20 million in Africa [4]. In Tanzania, where rabies is endemic, it is estimated to cause over 1,400 annual deaths [6]. The direct medical cost associated with a complete regime of post-exposure prophylaxis (PEP) is estimated at an average of $100 per person in the country [4]. These expenses impose a substantial burden, particularly on impoverished and rural communities where access to preventive measures such as vaccination may be limited. Geita is among the districts in Tanzania that experience a notable burden of rabies cases among human and animal populations, where in 2023, there were about 11 rabies cases in the region.
Dog vaccination is considered one of the most cost-effective methods for preventing and controlling dog-mediated human rabies and associated deaths [7]. Evidence shows that an increase in domestic dog vaccination coverage is strongly associated with a decrease in the incidences of rabies [8, 9]. This is because 99% of human exposures occur through rabid dogs [10, 11]. Also, prompt administration of PEP prevents human rabies in victims of dog bites [12]. Unfortunately, the cost of PEP can be a significant barrier for bite victims and governments in LMICs [13, 12]. Although dog vaccination against rabies is mandatory for every owner in Tanzania, the vaccine is considered a private good. Therefore, owners are usually charged a fee to vaccinate each dog. However, the higher the cost, the lower the compliance is likely to be [14]. Therefore, before setting the prices, it is essential to understand whether communities see the value of rabies vaccination and are willing to pay for the associated benefits. The willingness to pay enables involved parties to determine the price that will promote the uptake of rabies vaccination services among vulnerable communities.
Willingness to pay (WTP) is one of the important economic values. It is a fundamental economic concept that provides insights into consumers’ preferences, elasticity of demand, and perceived benefits of the good or service [15]. The WTP analysis has been used in a different field for economic valuation to estimate the economic value of non-market goods and services such as environmental services [16], forest management [17], and health interventions [18–20]. Willingness to pay for healthcare services has been reported to correlate with age, education, income, household size, perception/perceived risk, healthcare quality, locality, and ability to pay [21–23]. WTP has been used in Rabies studies to estimate the monetary value individuals place on services such as dog vaccine costs and vaccination cards [14, 24, 25]. However, no studies have been conducted individually on WTP for human rabies vaccine. Understanding WTP for rabies interventions is key to improving policies and programmatic strategies to enhance access to rabies vaccination services and reduce the burden of rabies, particularly in resource-limited settings. Therefore, his paper aims to provide insights into the economic preferences and priorities of residents regarding rabies prevention and control strategies by evaluating community willingness to pay for rabies vaccination services (Dog vaccines and human vaccines) in Geita District, Tanzania. The conceptual framework guiding this study is rooted in health economics and behavioural economics theories, which recognise the interplay between individual perceptions, socio-economic factors, and healthcare decision-making processes.